NeuroSense Therapeutics Ltd. (NRSN) KPIs and segments
NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
$1.51−0.05 (-3.51%)
Close on Nov 17, 2026Market cap $2.77MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive NeuroSense Therapeutics's business
Coming soon
This tab will track the numbers specific to NeuroSense Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?